Market Cap

NervGen Pharma Corp Market Capitalization:

C$628.2 Million

CAD as of Jan. 1, 2026

US$458.3 Million

business NervGen Pharma Corp Company Profile

NervGen Pharma Corp Main Stock Listing

TSXV: NGEN

Market Capitalization History of NervGen Pharma Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of NervGen Pharma Corp market cap

Date Market Cap YoY Change
Jan. 1, 2026 C$628.2 M 238.42%
Jan. 1, 2025 C$185.6 M 29.97%
Jan. 1, 2024 C$142.8 M 22.92%
Jan. 1, 2023 C$116.2 M -11.97%
Jan. 1, 2022 C$132.0 M -4.49%
Jan. 1, 2021 C$138.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

NervGen Pharma Corp Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

NervGen Pharma Corp has the following listings and related stock indices.


Stock: TSXV: NGEN

Stock: OTC: NGENF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.